175655-05-7

Basic information

• Product Name: 2-(2-AMINO-1,3-THIAZOL-4-YL)-4-CHLOROPHENOL
• Synonyms: 2-(2-AMINO-THIAZOL-4-YL)-4-CHLORO-PHENOL;2-(2-AMINO-1,3-THIAZOL-4-YL)-4-CHLOROPHENOL
• CAS NO: 175655-05-7
• Molecular Formula: C₉H₇ClN₂OS
• Molecular Weight: 226.68
• Mol File: 175655-05-7.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-(2-AMINO-1,3-THIAZOL-4-YL)-4-CHLOROPHENOL(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2-AMINO-1,3-THIAZOL-4-YL)-4-CHLOROPHENOL(175655-05-7)
• EPA Substance Registry System: 2-(2-AMINO-1,3-THIAZOL-4-YL)-4-CHLOROPHENOL(175655-05-7)

Safety Data

• Hazard Codes: T
• Statements: 25
• Safety Statements: 45
• Hazardous Substances Data: 175655-05-7(Hazardous Substances Data)

Usage

Uses

Used in Industrial Applications:
2-(2-Amino-1,3-thiazol-4-yl)-4-chlorophenol is used as a biocide for controlling microbial contamination in various industrial processes. Its effectiveness in inhibiting the growth of microorganisms helps maintain product quality and safety.
Used in Agricultural Applications:
In agriculture, 2-(2-Amino-1,3-thiazol-4-yl)-4-chlorophenol is used as a fungicide and bactericide to protect crops from diseases caused by microbial pathogens. This helps ensure a healthy and productive yield.
Used in Medical Settings:
2-(2-Amino-1,3-thiazol-4-yl)-4-chlorophenol is studied for its potential use as an antimicrobial agent in medical settings. Its ability to inhibit the growth of harmful microorganisms can contribute to a cleaner and safer healthcare environment, reducing the risk of infections.

Upstream product

• 52727-99-8 2-bromo-1-(5-chloro-2-hydroxyphenyl)-1-ethanone 
• 17356-08-0 thiourea 
• 1450-74-4 5-chloro-2-hydroxyacetophenone 

Downstream Products

• 1223515-79-4 C₁₄H₈ClN₃O₂S₂ 

Relevant articles and documents

IMMUNITY-RELATED PROTEIN KINASE INHIBITORS

[From equivalent EP1510210A1] A medicament having an inhibitory activity against IKK-Aβ and/or MEKK-1 or other protein kinases structurally similar thereto, which comprises as an active ingredient a substance selected from the group consisting of a compound represented by the following general formula (I) and a pharmacologically acceptable salt thereof, and a hydrate thereof and a solvate thereof: wherein X represents a connecting group whose number of atoms in the main chain is 2 to 5 (said connecting group may be substituted), A represents hydrogen atom or acetyl group, E represents an aryl group which may be substituted or a hetero aryl group which may be substituted, ring Z represents an arene which may have one or more substituents in addition to the group represented by formula -O-A wherein A has the same meaning as that defined above and the group represented by formula -X-E wherein each of X and E has the same meaning as that defined above, or a heteroarene which may have one or more substituents in addition to the group represented by formula -O-A wherein A has the same meaning as that defined above and the group represented by formula -X-E wherein each of X and E has the same meaning as that defined above.

INHIBITORS AGAINST THE ACTIVATION OF AP-1 AND NFAT

A medicament inhibiting the activation of AP-1 which comprises as an active ingredient a substance selected from the group consisting of a compound represented by the following general formula (I) and a pharmacologically acceptable salt thereof, and a hydrate thereof and a solvate thereof: wherein X represents a connecting group whose number of atoms in the main chain is 2 to 5 (said connecting group may be substituted), A represents hydrogen atom or acetyl group, E represents an aryl group which may be substituted or a hetero aryl group which may be substituted, ring Z represents an arene which may have one or more substituents in addition to the group represented by formula -O-A wherein A has the same meaning as that defined above and the group represented by formula -X-E wherein each of X and E has the same meaning as that defined above, or a heteroarene which may have one or more substituents in addition to the group represented by formula -O-A wherein A has the same meaning as that defined above and the group represented by formula -X-E wherein each of X and E has the same meaning as that defined above.

ANTIALLERGIC

A medicament for the preventive and/or therapeutic treatment of allergic diseases and/or endometriosis and/or hysteromyoma which comprises as an active ingredient a substance selected from the group consisting of a compound represented by the following general formula (I) and a pharmacologically acceptable salt thereof, and a hydrate thereof and a solvate thereof: wherein X represents a connecting group whose number of atoms in the main chain is 2 to 5 (said connecting group may be substituted), A represents hydrogen atom or acetyl group, E represents an aryl group which may be substituted or a hetero aryl group which may be substituted, ring Z represents an arene which may have one or more substituents in addition to the group represented by formula -O-A wherein A has the same meaning as that defined above and the group represented by formula -X-E wherein each of X and E has the same meaning as that defined above, or a heteroarene which may have one or more substituents in addition to the group represented by formula -O-A wherein A has the same meaning as that defined above and the group represented by formula -X-E wherein each ofX and E has the same meaning as that defined above.